Vistra's 11% pop on conditional DOE loan adds financing optionality but not near-term value

What happened

Vistra shares jumped 11% after the company announced a conditional $4.2 billion DOE loan to support 433 megawatts of nuclear uprates and 20-year life extensions at three plants. The financing is conditional and does not change the fact that the uprates remain in development and will not contribute earnings until 2031 or later under existing PPA schedules. Last quarter's 30% EBITDA growth to ~$1.8 billion was driven by higher capacity and energy prices, but the stock already trades at 13.2x EV/EBITDA and 24.5x P/E. Our prior WAIT rating was premised on insufficient margin of safety at $147, and the post-announcement price likely exceeds our $165 trim level, making the risk/reward worse. The market is treating optionality as certainty, while operational execution on Cogentrix, Meta deliveries, and ERCOT verification remains the real driver.

Implication

The conditional loan does not de-risk the 433 MW uprates because regulatory and engineering advancement is still pending, and the earliest contribution is 2031. Investors should not extrapolate the 11% move as validation of the AI-power thesis; the actual earnings bridge depends on Cogentrix closing by late 2026 and Meta deliveries starting on time. With the stock likely above our $165 trim threshold, the margin of safety is negative, and the base-case implied value of $155 is now below market. We would wait for pullbacks toward $135, where PJM scarcity and contracted earnings provide a better reward-to-risk, or for evidence that the DOE loan converts to unconditional funding with accelerated timelines. Monitor ERCOT verification and Helix customer awards as the next catalysts; without them, the stock is priced for perfection.

Thesis delta

The core thesis remains unchanged: Vistra is a high-quality integrated power company, but valuation at ~24.5x P/E leaves no margin of safety. The conditional DOE loan adds long-dated optionality but does not alter near-term cash flows or the timing risks on Cogentrix and Meta contracts. We maintain our WAIT rating and would only become constructive on a pullback to $135.